Sguigna, Peter V.
41  Ergebnisse:
Personensuche X
?
2

Cladribine tablets after treatment with natalizumab (CLADRI..:

Sguigna, Peter V. ; Hussain, Rehana Z. ; Okai, Annette...
Therapeutic Advances in Neurological Disorders.  17 (2024)  - p. , 2024
 
?
3

Subclinical optic neuritis in pediatric myelin oligodendroc..:

Nguyen, Linda ; Wang, Cynthia X. ; Conger, Darrel L....
Multiple Sclerosis and Related Disorders.  76 (2023)  - p. 104802 , 2023
 
?
5

Disease associations of excessive daytime sleepiness in mul..:

Sguigna, Peter V ; Toranian, Sabeen ; Tardo, Lauren M...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  9 (2023)  1 - p. 205521732311595 , 2023
 
?
 
?
10

The sequential natalizumab – alemtuzumab therapy in patient..:

Hussain, Rehana Z ; Sguigna, Peter V ; Okai, Annette...
Journal of Central Nervous System Disease.  14 (2022)  - p. 117957352211239 , 2022
 
?
11

Asymptomatic retinal vasculopathy in neuropsychiatric syste..:

Sguigna, Peter V. ; Tardo, Lauren ; Conger, Darrel..
Journal of the Neurological Sciences.  430 (2021)  - p. 118053 , 2021
 
?
12

Sterol-induced degradation of HMG CoA reductase depends on ..:

Jo, Youngah ; Lee, Peter C. W. ; Sguigna, Peter V..
Proceedings of the National Academy of Sciences of the United States of America.  108 (2011)  51 - p. 20503-20508 , 2011
 
?
 
?
14

Sterol-induced degradation of HMG CoA reductase depends on ..:

Jo, Youngah ; Lee, Peter C. W. ; Sguigna, Peter V..
Proceedings of the National Academy of Sciences.  108 (2011)  51 - p. 20503-20508 , 2011
 
?
 
1-15